PITUITARY ADENYLATE-CYCLASE ACTIVATING POLYPEPTIDE (PACAP) AND VASOACTIVE-INTESTINAL-PEPTIDE STIMULATE 2 SIGNALING PATHWAYS IN CHO CELLS STABLY TRANSFECTED WITH THE SELECTIVE TYPE-I PACAP RECEPTOR
C. Delporte et al., PITUITARY ADENYLATE-CYCLASE ACTIVATING POLYPEPTIDE (PACAP) AND VASOACTIVE-INTESTINAL-PEPTIDE STIMULATE 2 SIGNALING PATHWAYS IN CHO CELLS STABLY TRANSFECTED WITH THE SELECTIVE TYPE-I PACAP RECEPTOR, Molecular and cellular endocrinology, 107(1), 1995, pp. 71-76
The properties of the pituitary adenylate cyclase activating polypepti
de (PACAP) type I receptor were studied on a clone of Chinese hamster
ovary cells (CHO) stably transfected with the recombinant receptor. PA
CAP(1-27), PACAP(1-38) and VIP inhibited [I-125-acetyi-His(1)]PACAP(1-
27) binding, stimulated cyclic AMP and inositol phosphates production
and induced [Ca2+](i) increase with the same order of potency: PACAP(1
-27)=PACAP(1-38) > VIP. The concentrations required for half maximal r
eceptor occupancy, IP3- and [Ca2+](i) increase were not different for
both PACAPs (1 nM) and 100-fold higher than those required for cyclic
AMP increase (0.010 nM). These data suggest that the occupancy of a po
rtion of the total receptors available was sufficient for maximal cycl
ic AMP production but not for maximal IP3 production. It is concluded
that the possibility of the type I PACAP receptor being coupled to a t
ransduction pathway is not located at the level of the ligand but rath
er at the level of the G-proteins.